Zhejiang East-Asia Pharmaceutical (605177.SH): The raw material drug Lu Likang received the South Korean raw material drug registration certificate.
East Asia Pharmaceutical (605177.SH) issued an announcement that they recently received approval from the South Korean Food and Drug Administration (Korea...
Zhejiang East-Asia Pharmaceutical (605177.SH) announced that recently, the company has received the raw material drug registration certificate from the South Korean Ministry of Food and Drug Safety (Korean MFDS) for the product named Voriconazole. Voriconazole is used to treat skin superficial fungal infections caused by sensitive fungi, such as athlete's foot, body ringworm, jock itch, and can also be used for cutaneous candidiasis and tinea versicolor.
The receipt of the Voriconazole raw material drug registration certificate in South Korea marks the company's eligibility for market access in South Korea. This will have a positive impact on expanding the company's presence in the South Korean pharmaceutical market, thus promoting the sales of Voriconazole raw material drugs in other overseas markets.
Related Articles
HK Stock Market Move | CHINA FOODS (00506) rose nearly 5% again. The stock price has almost doubled since the beginning of the year. The company plans to strategically enter the nutrition and health food market.
HK Stock Market Move | POP MART (09992) rose more than 3% recently due to fluctuations in the second-hand price, which is related to supply adjustment. Institutions are optimistic about the company's long-term development prospects.
HK Stock Market Move | GUOFUHEE (02582) rose over 14% during trading hours, formally signed a cooperation agreement with South Korean company Hylium, accelerating its layout in the hydrogen energy market in East Asia.
HK Stock Market Move | CHINA FOODS (00506) rose nearly 5% again. The stock price has almost doubled since the beginning of the year. The company plans to strategically enter the nutrition and health food market.
HK Stock Market Move | POP MART (09992) rose more than 3% recently due to fluctuations in the second-hand price, which is related to supply adjustment. Institutions are optimistic about the company's long-term development prospects.
HK Stock Market Move | GUOFUHEE (02582) rose over 14% during trading hours, formally signed a cooperation agreement with South Korean company Hylium, accelerating its layout in the hydrogen energy market in East Asia.
